BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18004114)

  • 1. Use of ischemia-modified albumin in diagnosis of coronary artery disease.
    Kalay N; Cetinkaya Y; Basar E; Muhtaroglu S; Ozdogru I; Gul A; Eryol NK; Oguzhan A; Abaci A
    Coron Artery Dis; 2007 Dec; 18(8):633-7. PubMed ID: 18004114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.
    Sinha MK; Gaze DC; Tippins JR; Collinson PO; Kaski JC
    Circulation; 2003 May; 107(19):2403-5. PubMed ID: 12742986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia-modified albumin in relation to exercise stress testing.
    Sbarouni E; Georgiadou P; Theodorakis GN; Kremastinos DT
    J Am Coll Cardiol; 2006 Dec; 48(12):2482-4. PubMed ID: 17174185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of ischemia-modified albumin in patients with acute coronary syndrome].
    Shen XL; Xing C; Han LL; Lin L; Lin LF; Deng YL; Pu XD; Hu XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Sep; 35(9):814-7. PubMed ID: 18070473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification.
    Zhong Y; Wang N; Xu H; Hou X; Xu P; Zhou Z
    Coron Artery Dis; 2012 Dec; 23(8):538-41. PubMed ID: 22936021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemia modified albumin in relation to pharmacologic stress testing in coronary artery disease.
    Sbarouni E; Georgiadou P; Panagiotakos D; Kyrzopoulos S; Tsiapras D; Voudris V; Kremastinos DT
    Clin Chim Acta; 2008 Oct; 396(1-2):58-61. PubMed ID: 18644358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycle-ergometry stress testing and use of chronotropic reserve adjustment of ST depression for identification of significant coronary artery disease in clinical practice.
    Palmieri V; Pezzullo S; Arezzi E; D'Andrea C; Cassese S; Martino S; Celentano A
    Int J Cardiol; 2008 Jul; 127(3):390-2. PubMed ID: 17586070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cycle ergometer stress testing for identification of significant coronary artery disease: improved accuracy by the use of chronotropic reserve adjustment of ST-segment depression].
    Palmieri V; Pezzullo S; Arezzi E; Russo C; Martino S; D'Andrea C; Cassese S; Celentano A
    G Ital Cardiol (Rome); 2008 Sep; 9(9):627-36. PubMed ID: 18783083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Samimi-Fard S; Kaski JC
    Clin Chim Acta; 2008 Feb; 388(1-2):196-9. PubMed ID: 18036561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics of angina pectoris in patients of coronary artery disease complicated with renal stenosis and the diagnostic value thereof: analysis of 2820 cases].
    Fan ZJ; Yan JH; Chen HY; Li Q; Fang Q; Zhang SY; Shen ZJ; Wang CH; Jin XF; Zeng Y; Liu ZY; Xie HZ; Li HW; Liu YT
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2986-90. PubMed ID: 18261331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischaemia-modified albumin elevation after percutaneous coronary intervention reflects albumin concentration rather than ischaemia.
    Demir H; Topkaya BC; Erbay AR; Dogan M; Yücel D
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):327-31. PubMed ID: 19487408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischaemia-modified albumin in pulmonary hypertension.
    Sbarouni E; Georgiadou P; Manginas A; Panagiotakos D; Karavolias GK; Voudris V
    Biomarkers; 2010 May; 15(3):238-42. PubMed ID: 19995310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome.
    Lee YW; Kim HJ; Cho YH; Shin HB; Choi TY; Lee YK
    Clin Chim Acta; 2007 Sep; 384(1-2):24-7. PubMed ID: 17570353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of ischaemia modified albumin during ongoing severe myocardial ischaemia.
    Hjortshøj S; Dethlefsen C; Kristensen SR; Ravkilde J
    Clin Chim Acta; 2009 May; 403(1-2):114-20. PubMed ID: 19361451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin cobalt binding assay to rule out acute coronary syndrome.
    Abadie JM; Blassingame CL; Bankson DD
    Ann Clin Lab Sci; 2005; 35(1):66-72. PubMed ID: 15830711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia modified albumin, a marker of acute ischemic events: a pilot study.
    Talwalkar SS; Bon Homme M; Miller JJ; Elin RJ
    Ann Clin Lab Sci; 2008; 38(2):132-7. PubMed ID: 18469358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
    Katerinis I; Nguyen QV; Magnin JL; Descombes E
    Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
    Najjar SS; Bottomley PA; Schulman SP; Waldron MM; Steffen RP; Gerstenblith G; Weiss RG
    J Cardiovasc Magn Reson; 2005; 7(4):657-66. PubMed ID: 16136855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of myocardial ischemia and heart rate to ST segment changes in patients with or without coronary artery disease.
    Häggmark S; Haney MF; Johansson G; Reiz S; Näslund U
    Acta Anaesthesiol Scand; 2008 Feb; 52(2):219-28. PubMed ID: 17999710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of physical exercise and relationship with biochemical variables of NT-pro-brain natriuretic peptide and ischemia modified albumin.
    Lippi G; Salvagno GL; Montagnana M; Schena F; Ballestrieri F; Guidi GC
    Clin Chim Acta; 2006 May; 367(1-2):175-80. PubMed ID: 16388789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.